Atrial fibrillation trials recruiting in Tennessee

All Atrial fibrillation trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Chattanooga, Knoxville, Memphis, Nashville
• BoxX-NoAF Clinical Trial
  NCT06989775 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Tennessee: Nashville
• Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
  NCT05723926 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Chattanooga, Memphis
• Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
  NCT07298473 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville
• Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
  NCT06575881 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville
• STOP AF First Post-Approval Study
  NCT05227053 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Germantown, Memphis
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Jefferson City
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Tullahoma
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
  NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Tullahoma
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Tennessee: Chattanooga, Elizabethton, Germantown, Jefferson City
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Brentwood, Memphis
• Tracking Results of Ablations to Combat AF Registry Generation 2
  NCT05111015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Jackson, Nashville